SCHEMBL10183324

SCHEMBL10183324

O=C(O[C@H]1CCOC1)N1CCN(CC(=O)N(c2cccc(F)c2)C2C(=O)N(C3CCCCC3)c3ccccc32)CC1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 4/20 0.37
▸ ADAM10 O14672 6/20 0.35
▸ MMP2 P08253 3/20 0.35
▸ MMP3 P08254 1/20 0.35
▸ MMP9 P14780 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ DRD2 P14416 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CCKAR P32238 2/20 0.32
▸ CCKBR P32239 2/20 0.32
▸ AGTR2 P50052 1/20 0.32
▸ OPRM1 P35372 2/20 0.32
▸ OPRK1 P41145 2/20 0.32
▸ OPRL1 P41146 2/20 0.32
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10185708 0.87 LMNA (0.41) IDH1ALDH1A1MEN1KMT2AAGTR2
SCHEMBL10185674 0.86 IDH1 (0.48) IDH1HTR1ADRD2HTR2AALDH1A1
SCHEMBL10183330 0.81 IDH1 (0.48) IDH1HTR1ADRD2HTR2AALDH1A1
SCHEMBL10184102 0.80 IDH1 (0.37) IDH1MMP3MMP9HTR1ADRD2
SCHEMBL10183756 0.79 TSHR (0.44) IDH1ALDH1A1KMT2AAGTR2OPRM1
SCHEMBL10183299 0.78 OPRM1 (0.40) IDH1CCKARCCKBRAGTR2OPRM1
SCHEMBL10184038 0.78 KMT2A (0.36) IDH1ALDH1A1MEN1KMT2ACCKBR
SCHEMBL10184119 0.77 OPRM1 (0.37) IDH1CCKARCCKBRAGTR2OPRM1
SCHEMBL10183319 0.77 MEN1 (0.43) IDH1ALDH1A1MEN1KMT2ACCKAR
SCHEMBL10183337 0.77 OPRM1 (0.39) IDH1MEN1KMT2ACCKARCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback